Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Personalized approach to prostate cancer prognosis
M. J. Donovan
, J. Costa
, C. Cordon-Cardo
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Personalized approach to prostate cancer prognosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Biopsy Specimen
100%
Prostate Needle Biopsy
100%
Prostate Cancer Prognosis
100%
Personalized Approach
100%
Prostatectomy Specimen
100%
Patient Management
50%
Specific Risk
50%
Risk Profile
50%
Health Outcomes
50%
Histology
50%
Systems-based
50%
Tumor Subtype
50%
Treatment Decisions
50%
Decision Process
50%
Genetic Risk
50%
Prostate Cancer
50%
Urologists
50%
Pathologic
50%
Patients with Prostate Cancer
50%
Prostate-specific Antigen
50%
Breast Cancer
50%
Specific Features
50%
Personalized Medicine
50%
Tumor Differentiation
50%
Nomogram
50%
Diagnostic Study
50%
Clinical Judgment
50%
Individual Risk
50%
Patient-specific
50%
Prognostic Features
50%
Gleason
50%
Volume of Disease
50%
Tumor Length
50%
Total Prostate-specific Antigen
50%
Margin Status
50%
Positive Cores
50%
Diagnosis Stage
50%
Specific Imaging
50%
Ancillary
50%
Pathological Stage
50%
Genetic Comorbidity
50%
Working Diagnosis
50%
Clinical Decision-making
50%
Disease Extent
50%
Patient Attributes
50%
Medicine and Dentistry
Prostate Cancer
100%
Cancer Prognosis
100%
Prostatectomy
66%
Neoplasm
66%
Prostate Specific Antigen
66%
Needle Biopsy
66%
Urologist
33%
Decision Making
33%
Breast Cancer
33%
Clinical Decision Making
33%
Tumor Differentiation
33%
Health Outcomes
33%
Genetic Risk
33%
Personalized Medicine
33%
Statistical Modeling
33%
Comorbidity
33%
Diseases
33%
Histology
33%